Source: Journal of Clinical Pathology. Unidade: FMRP
Subjects: ANTICORPOS, METABOLISMO, PROTEÍNAS, IMUNOHISTOQUÍMICA, NEOPLASIAS OVARIANAS, MORTALIDADE, FATORES DE RISCO
ABNT
TEIXEIRA, Lorena Alves e REIS, Francisco José Candido dos. Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review. Journal of Clinical Pathology, v. 73, n. 4, p. 191-196, 2020Tradução . . Disponível em: https://doi.org/10.1136/jclinpath-2019-206276. Acesso em: 09 nov. 2024.APA
Teixeira, L. A., & Reis, F. J. C. dos. (2020). Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review. Journal of Clinical Pathology, 73( 4), 191-196. doi:10.1136/jclinpath-2019-206276NLM
Teixeira LA, Reis FJC dos. Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review [Internet]. Journal of Clinical Pathology. 2020 ; 73( 4): 191-196.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1136/jclinpath-2019-206276Vancouver
Teixeira LA, Reis FJC dos. Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review [Internet]. Journal of Clinical Pathology. 2020 ; 73( 4): 191-196.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1136/jclinpath-2019-206276